1. Introduction
Ischemic heart disease is closely associated with atherosclerosis and is a condition of insufficient blood flow to the heart through the three major coronary arteries. Hyperlipidemia, diabetes, obesity, high blood pressure, and smoking are well-known risk factors that facilitate the buildup of fats, cholesterols, and blood clots on the walls of the blood vessels. These plaques damage the endothelial cells and reduce or even block the blood flow. Ischemic heart disease is commonly treated in three stages.
The first therapeutic approach includes exercise, diet, medications, percutaneous transluminal coronary angioplasty (PTCA), and stent insertion. As a next step, when medical stent insertion is not available, coronary artery bypass grafting (CABG) surgery can be performed. Lastly, if the treatment effects or symptom improvements achieved by the previous medical and surgical procedures are not sufficient and additional surgery is not a viable option, or the effect of pharmacological treatment is limited, an enhanced external counter pulsation (EECP) procedure is applied to the patient.
In the EECP procedure, a patient lies on the bed wearing cuffs on the legs at the calves and thighs, and buttocks (or upper thighs). The cuffs are inflated during diastole, applying external pressure on the body, and deflated during systole, releasing the applied pressure.
The timing of sequential inflation and deflation is synchronized with the cardiac cycle. During diastole, the pressure exerted by the cuffs facilitates the blood flow from the legs to the upper body; during systole, the blood flow to the lower body increases as the cuffs deflate, strengthening the myocardium and facilitating new blood vessel formation. With these benefits alone, EECP can have therapeutic effects on patients with angina or myocardial infarction [
1,
2,
3,
4,
5]. Furthermore, the therapeutic effects of EECP include vascular endothelial cell activation, aging prevention through enhanced blood circulation and oxygen supply, increased blood flow to the brain and kidneys, blood vessel regeneration, toxins, blood plaque clearance, and regeneration of new blood vessels [
6].
A typical EECP treatment consisting of 35 one-hour sessions (five days a week over seven weeks) can increase blood flow around clogged blood vessels by activating the surrounding dormant blood vessels [
7]. Based on these benefits, EECP treatment is recommended for cases where medical or surgical treatments cannot be considered [
8]. As shown in
Figure 1, traditional EECP treatment uses a pneumatic system where two to three air compressors are placed under the bed. Compressed air is instantaneously injected into the cuffs wrapped around the patient’s legs during the diastole phase of the patient’s cardiac cycle.
Since its initial development in the 1960s, EECP technology has not seen much progress [
9].
The machine tends to generate operational noise and heat, and physical impact on the patient’s body, but the technology to address these issues has not yet been developed. The operational noise causes discomfort to both patients and medical staff, and persistent exposure to this noise can cause noise-induced hearing loss.
In this study, an electric EECP machine was developed to overcome the shortcomings (noise and shocks on the body) of conventional EECP machines. In general, hospital noise levels need to be controlled and limited to 50 dB or lower to prevent the noise from discomforting and disturbing other patients [
10,
11,
12,
13,
14].
By replacing the air compressors with electrical motors, the disturbing noise and physical impact on the body were resolved. In addition, the motors can be electronically controlled for each compression target (calves, thighs, buttocks), which means that the compression timings and pressures can be set individually. This capability is essential for the development of a treatment scheme that is optimized for the patient’s cardiac state and cuff locations.
Since the effect of each cuff on the blood flow can be analyzed, the cuff locations, number of cuffs, and compression timing in relation to other cuffs can be fine-tuned for each patient to achieve the maximum EECP effect. By removing the air compressors, a core component of the pneumatic system, the electric leg compression machine developed in this study, was designed to produce lower levels of operating noise and to allow easy transportation of the entire machine, as shown in
Figure 2.
In the new electric leg compression machine, electrical motors, replacing the air compressors, apply pressure on the legs by repeatedly inflating and deflating the cuffs. The motors need to repeat clockwise and counter-clockwise rotations in a short period, and accordingly, the gears should mesh and rotate.
4. Noise Level Analysis Results
The level of noise generated by rotating gears was measured at the top cover of the medical compression machine.
The main cover is in contact with the body, so it does not propagate noise. The results of an analysis of the eight cases are summarized in
Figure 13. In
Figure 13, the noise patterns were represented with STFT plots. In the STFT plots, the time and frequency were shown on the horizontal and vertical axis, respectively, and the color contour indicates the amplitude (dB) of the frequency component.
The plots were generated by sequentially overlapping frequency transformations for a specific time interval (0.05 s).
Figure 12a shows the analysis results of the initial model. In all cases, the noise level peaks at 950 Hz, which is the GMF component of the gear pairs calculated using Equation (11).
This result suggests that the GMF component generated from the pair of gears has the most significant impact on the system.
The STFT results in
Figure 12 show the typical whine noise pattern caused by the meshing of the toothed gears. Whine noise is excited by the transmission error of mating gears and can be described as a resonance due to gear mesh frequency.
The highest noise level at the top cover and the weight of each case are summarized in
Table 5 and
Table 6.
The initial tolerance applied in Cases 1 and 2 increased the noise level to 1.3% and 2.7%, respectively. Poor bearing assembly was found to have a more significant effect.
Combining
Table 5 and
Table 6, the following results can be obtained. In Case 3, where the cover material was changed from polycarbonate to aluminum, a material with a better sound absorption property, the weight increased by 8.4% while the noise level was reduced by 8.2%. For Case 4, where the driven gear material was changed from S45C to polyacetal, the noise level and weight were reduced by 7.5% and 8.5%, respectively. Both the weight and noise level could be reduced by changing the material for the driven gear. The fatigue strength of S45C and polyacetal are 307.7 [
21] and 40~45 MPa [
22], respectively. The polyacetal gears are vulnerable to fatigue because gears are exposed to repeated loads. For Cases 5–7, structural reinforcement increased the weight, but the noise levels were lowered. For Case 5, the gear cover was enclosed with the solid frame, the weight increased by 21.5% (600 g), and the most significant level of noise reduction was achieved—11.8%.
This result could be attributed to the sealed gear cover, through which significant noise is propagated. The arch-shaped reinforcement also increased the weight of Case 6 by 1.9%, but the noise level was reduced by 7.2%. Increased cover thickness in Case 7 also increased the weight by 2.1%, with a noise reduction of 7.2%. Based on these results, structural reinforcement (Case 6) and increased cover thickness (Case 7) are preferred for noise reduction while keeping the weight increase minimal. Reduced gear thickness and a consequent decrease in weight and contact area of the gears led to noise reduction (Case 8). However, as described earlier, the pressure required for therapeutic body compression is 40 kPa.
The load required to achieve this pressure level is applied to the gears in contact, and therefore, increased stress due to a smaller contact area may cause fatigue problems.